Free Trial
ASX:ATX

Amplia Therapeutics (ATX) Stock Price, News & Analysis

Amplia Therapeutics logo

About Amplia Therapeutics Stock (ASX:ATX)

Advanced Chart

Key Stats

Today's Range
N/A
50-Day Range
N/A
52-Week Range
N/A
Volume
77,249 shs
Average Volume
N/A
Market Capitalization
A$30.65 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive ATX Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Amplia Therapeutics and its competitors with MarketBeat's FREE daily newsletter.

ATX Stock News Headlines

Elon’s BIGGEST warning yet?
Tesla's About to Prove Everyone Wrong... Again Back in 2018, when Jeff Brown told everyone to buy Tesla… The "experts" said Elon was finished and Tesla was headed for bankruptcy. Now they're saying the same thing, but Jeff has uncovered Tesla's next breakthrough.
See More Headlines

ATX Stock Analysis - Frequently Asked Questions

Industry, Sector and Symbol

Stock Exchange
ASX
Sector
Medical
Industry
Biotechnology
Sub-Industry
N/A
Current Symbol
ASX:ATX
CIK
N/A
Fax
N/A
Employees
N/A
Year Founded
N/A

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-A$4.50 million
Net Margins
-101.14%
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
A$4.45 million
Price / Cash Flow
4.88
Book Value
A$0.06 per share
Price / Book
N/A

Miscellaneous

Free Float
N/A
Market Cap
A$30.65 million
Optionable
Not Optionable
Beta
0.72
(Almost)  Everything You Need To Know About The EV Market Cover

Looking to profit from the electric vehicle mega-trend? Enter your email address and we'll send you our list of which EV stocks show the most long-term potential.

Get This Free Report

This page (ASX:ATX) was last updated on 7/6/2025 by MarketBeat.com Staff
From Our Partners